Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritis

INTRODUCTION: Rational selection of disease modifying anti-rheumatic drugs in the treatment of rheumatoid arthritis (RA) has many potential advantages, including rapid disease control, reduced long-term disability and reduced overall cost to the healthcare system. Inter-individual genetic difference...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Wiese, Michael D, Schnabl, Matthew, O'Doherty, Catherine, Spargo, Llewellyn D, Sorich, Michael J, Cleland, Leslie G, Proudman, Susanna M
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2012
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3580556/
https://ncbi.nlm.nih.gov/pubmed/22784880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar3911
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים